Frailty, Hip Fractures and Inflammatory Biomarkers
- Conditions
- FrailtyHip FractureInflammatory Biomarkers
- Registration Number
- NCT06614478
- Lead Sponsor
- University of Thessaly
- Brief Summary
We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.
- Detailed Description
Frailty (F) is a prevalent syndrome among elderly patient with hip fractures (HF) and has been linked to poor prognosis. Inflammatory biomarkers have been used as prognostic indexes in patients with HF. We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
- age >65 years, ASA PS I-III, non- institutionalized, able to communicate patients
- Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frailty status preoperatively Frailty will be categorized based on the validated Groningen Frailty Indicator (GFI) as non-frail (NF, score 0,1), pre-frail (PF, score 2, 3) and severe frail (SF, score \>4).
Inflammatory biomarkers preoperatively Upon admission and immediate before surgery upper limits of white blood cells (WBC) within normal range (WBC \>8 10\^3/μL), NLR (neutrophils/lymphocytes), PLR (platelets/lymphocytes), CRP (C-reactive protein) and CLR (CRP/lymphocytes), will be recorded.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Larissa University Hospital
🇬🇷Larissa, Thessaly, Greece
UHL
🇬🇷Larissa, Thessaly, Greece